发明名称
摘要 The invention relates to a pharmaceutical composition comprising a compound of formula (1) wherein R1 is optionally substituted phenyl, optionally substituted pyridyl or optionally substituted indolyl; R2 is (CH2)n wherein n is 0, 1, 2, 3 or 4; R3 is (CH2)mR3A wherein m is 0, 1, 2, 3 or 4, and R3A is methyl, isopropyl, tert-butyl, OCH3, OH, optionally substituted phenoxy, C≡CH, C≡N, optionally substituted phenyl, furanyl or thienyl; A is a ring containing X1 with the meaning O, S, NH, N(CH3) or CH2; and X2 is O, S or NH; and a compound of formula (2) wherein R4 is optionally substituted phenyl, optionally substituted pyridyl, optionally substituted indolyl,—NR7R8; or—NH—N═CH—R9; and substituents R5 to R9 have the meanings indicated in the description, in particular ethionamide. The pharmaceutical composition is useful, e.g., in the treatment of multidrug-resistant tuberculosis.
申请公布号 JP2012530765(A) 申请公布日期 2012.12.06
申请号 JP20120516757 申请日期 2010.06.25
申请人 发明人
分类号 A61K31/365;A61K31/397;A61K31/40;A61K31/4015;A61K31/443;A61K31/4439;A61K31/495;A61K31/496;A61K31/5375;A61K31/5377;A61P31/06;C07D205/04;C07D207/06;C07D207/267;C07D213/36;C07D265/30;C07D295/18;C07D307/33;C07D401/06;C07D405/06;C07D409/06;C07D413/04 主分类号 A61K31/365
代理机构 代理人
主权项
地址